arrow
A

Atul Humar

University Health Network
H指数:84
被引数:2.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Virologic and exploratory immunologic characterization of relapsing human Cytomegalovirus (HCMV) DNAemia in solid organ transplant recipients: a prospective observational cohort study

复发性人类巨细胞病毒(HCMV)DNA血症的病毒学和探索性免疫学特征:一项前瞻性观察队列研究

2026-10-010
OAAI
Short-course prophylaxis with the Toronto HCV protocol for recipients of non-liver solid organ transplants from donors with hepatitis C viraemia: a retrospective, matched cohort study

对来自丙型肝炎病毒血症供体的非肝脏实体器官移植受者应用多伦多HCV方案进行短期预防:一项回顾性、匹配队列研究

2026-09-290
PRE
Longitudinal Innate and Heterologous Adaptive Immune Responses to SARS-CoV-2 JN.1 in Transplant Recipients With Prior Omicron Infection: Limited Neutralization but Robust CD4+ T-Cell Activity

SARS-CoV-2 JN.1在既往感染过Omicron的移植受者中引起的纵向固有和异源适应性免疫反应:有限的中和作用但CD4+ T细胞活性强

2025-07-020
OA
Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients: A multicenter cohort, 2015-2020

糖皮质激素辅助治疗实体器官移植受者的肺孢子虫肺炎: 多中心队列,2015-2020

2024-04-016
PRE
Immunogenicity and Safety of Booster SARS-CoV-2 mRNA Vaccine Dose in Allogeneic Hematopoietic Stem Cell Transplantation Recipients

加强SARS-CoV-2 mRNA疫苗剂量在异基因造血干细胞移植受者中的免疫原性和安全性

2023-11-016
OAAI
Immunogenicity, Safety, and Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infections After Coronavirus Disease 2019 Vaccination in Organ Transplant Recipients: A Prospective Multicenter Canadian Study
2023-04-138
OAAI
Safety and Immunogenicity After a Three-Dose SARS-CoV-2 Vaccine Schedule in Allogeneic Stem Cell Transplant Recipients

异基因干细胞移植受者三剂SARS-CoV-2疫苗方案后的安全性和免疫原性

2022-10-0127
OAAI